Johnson & Johnson JNJ
NYSE JNJ
$275.15 -3.32 (-1.19%)
At close: Sep 4, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Long-Term Debt Issuances (2009 - 2025)

Johnson & Johnson's (JNJ) quarterly Long-Term Debt Issuances came in at $9.1 billion in Q1 2025, up 456800.0% year-over-year from N/an in Q1 2024, and up 913700.0% quarter-over-quarter from $1.0 million in Q3 2024.

Analysis

Johnson & Johnson (JNJ) Long-Term Debt Issuances (2009 - 2025) Analysis & Trends

Johnson & Johnson has disclosed Long-Term Debt Issuances across 15 years of filings, most recently posting $9.1 billion for Q1 2025.

  • In Q1 2025, Long-Term Debt Issuances rose 456800.0% year-over-year to $9.1 billion; the TTM figure through Dec 2025 stood at $9.1 billion (up 37.21% YoY), while the FY2025 annual figure was $9.1 billion, up 37.21% from the prior year.
  • Long-Term Debt Issuances came in at $9.1 billion for Q1 2025 at Johnson & Johnson, up from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $9.1 billion in Q1 2025 to a low of -$7.7 billion in Q4 2023.
  • Average Long-Term Debt Issuances over 4 years is $1.8 billion, with a median of $2.0 million recorded in 2021.
  • Year-over-year, Long-Term Debt Issuances slumped 99.97% in 2024 and jumped 456800.0% in 2025.
  • Over 4 years, Long-Term Debt Issuances stood at $2.0 million in 2021, then sank by 383800.0% to -$7.7 billion in 2023, then soared by 100.01% to $1.0 million in 2024, then surged by 913700.0% to $9.1 billion in 2025.
  • Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $9.1 billion in Q1 2025, $1.0 million in Q3 2024, and $6.7 billion in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn -
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn -
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 1.98 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn -
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 4.88 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn -
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 30, 2025 9.14 Bn
Sep 29, 2024 1.00 Mn
Jun 30, 2024 6.66 Bn
Mar 31, 2024 2.00 Mn
Oct 1, 2023 -7.67 Bn
Apr 2, 2023 7.67 Bn
Jan 1, 2023 -1.00 Mn
Oct 3, 2021 2.00 Mn
Apr 4, 2021 1.00 Mn
Sep 27, 2020 7.43 Bn
Jun 28, 2020 1.00 Mn
Dec 29, 2019 2.00 Mn
Jun 30, 2019 1.00 Mn
Dec 30, 2018 -1.00 Mn
Sep 30, 2018 3.00 Mn
Jul 1, 2018 1.00 Mn
Apr 1, 2018 2.00 Mn
Dec 31, 2017 4.53 Bn
Oct 1, 2017 1.00 Mn
Apr 2, 2017 4.46 Bn